Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - TQG3902 "ANGIOTENSIN II" INJECTION APPROVED FOR CLINICAL TRIAL2023.11.01
-
VOLUNTARY ANNOUNCEMENT - PROGRESS ON THE "SHARE PURCHASE PLAN FOR AN AGGREGATE AMOUNT OF NOT EXCEEDING HK$1 BILLION2023.10.30
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.26
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.25
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.24
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.20
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.19
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2023.10.18